According to Future Market Insights’ most recent analysis, the global COVID-19 vaccine development tools market is expected to reach US$ 17.2 billion by 2021. The market is expected to increase by 10.7% between 2022 and 2032, which is a much larger rate than in the past. The category with the greatest potential for.
Covid-19 Vaccine Development Tools Market is projected to expand at a CAGR of around 10% during 2022 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The North America life science tools market size is expected to reach USD 81.9 billion by 2027 registering a CAGR of 11.6%
The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities.
Competitive dynamics continue to drive a rapid pace of innovation in sequencing, multiplex platforms, and major categories of mass spectrometry and liquid chromatography; this supports growth via upgrade/replacement cycles and expands the applicability of technologies. An increase in investments for R&D of life science tools is expected to drive the market significantly.
North America Life Science Tools Market 2020-2027: Opportunities in the Rise in the Number of Strategic Deals & Developments globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.